The specter of generic rivalry has repeatedly loomed over copyright’s famous drug, Sildenafil, sparking questions about the future of connected pharmaceutical investments. While early years saw significant returns, the intellectual property expiration has created the way for less expensive alternatives, possibly lowering revenue and creating a s… Read More